May 29, 2019 / 5:27 PM / 5 months ago

BUZZ-Zymeworks Inc rises on receiving $2 mln milestone payment from Merck

** U.S.-listed shares of Zymeworks Inc up 5% at $18.40

** The Canada-based drug developer says it has earned a milestone payment of $2 mln in connection with a research and license pact with Merck & Co

** Merck has a worldwide, royalty-bearing license to research, develop and commercialize certain therapies for which Zymeworks is eligible to receive additional milestone payments and royalties on product sales

** ZYME says it has strategic partnerships with 9 biopharma companies

** Earlier this month, the co announced expansion of a similar pact with British drugmaker GlaxoSmithKline Plc

** Up to Tuesday’s close, ZYME had risen 19.4% YTD (Reporting by Manojna Maddipatla)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below